Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20141
20152
20162
20173
20181
20191
20203
20211
20222
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Terminated3
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Centre Jean Perrin2
BeiGene USA, Inc.1
Bristol-Myers Squibb1
CarThera1
Celgene1
Centre Antoine Lacassagne1
Eli Lilly and Company1
Enterome1
Forma Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma22
Glioma5
Brain Neoplasms4
Carcinoma, Hepatocellular3
Sarcoma3
Astrocytoma2
Carcinoma, Non-Small-Cell Lung2
Cholangiocarcinoma2
Colorectal Neoplasms2
Diffuse Intrinsic Pontine Glioma2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.